DiaMedica Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Note 11 - Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2023

	December 31, 2023
Employee and non-employee stock options		3,871,013
Common shares issuable upon settlement of deferred stock units		213,905
Common shares issuable under common share purchase warrants		—
Shares available for grant under the Amended and Restated 2019 Omnibus Incentive Plan		927,215
Shares available for grant under the 2021 Employment Inducement Incentive Plan		395,000
Total		5,407,133